Source link : https://www.newshealth.biz/health-news/trial-points-to-best-practices-for-inhaled-insulin-in-type-1-diabetes/
ORLANDO — For type 1 diabetes patients, switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) maintained glycemic control — for those who used it as intended, the INHALE 3 trial showed. Overall glycemic control was similar between treatments, with an HbA1c at 17 weeks of 7.6% on the inhaled insulin […]
Author : News Health
Publish date : 2024-06-23 14:50:49
Copyright for syndicated content belongs to the linked Source.
Categories